H F Gao Selected Research

Residual Neoplasm

11/2020

Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (docetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H F Gao Research Topics

Disease

1	Breast Neoplasms (Breast Cancer) 11/2020
1	Residual Neoplasm 11/2020
1	Thrombocytopenia (Thrombopenia) 11/2020
1	Headache (Headaches) 01/2013
1	Constipation 01/2013
1	Fatigue 01/2013
1	Hiccup (Hiccups) 01/2013
1	Nausea 01/2013
1	Neoplasms (Cancer) 01/2013
1	Vomiting 01/2013
1	Inflammation (Inflammations) 01/2007
1	Multiple Sclerosis 01/2007
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2007

Drug/Important Bio-Agent (IBA)

1	Docetaxel (Taxotere)FDA Link 11/2020
1	Carboplatin (JM8)FDA LinkGeneric 11/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020
1	Epirubicin (Ellence)FDA LinkGeneric 11/2020
1	Aprepitant (Emend)FDA Link 01/2013
1	Palonosetron (Aloxi)FDA Link 01/2013
1	Cisplatin (Platino)FDA LinkGeneric 01/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2013
1	Monoamine Oxidase (MAO)IBA 01/2007
1	N'-(2-phenylallyl)hydrazineIBA 01/2007
1	human AOC3 proteinIBA 01/2007

Therapy/Procedure

1	Neoadjuvant Therapy 11/2020
1	Intravenous Infusions 11/2020
1	Drug Therapy (Chemotherapy) 01/2013